APA (7th ed.) Citation

Taktaz, F., Fontanella, R. A., Scisciola, L., Pesapane, A., Basilicata, M. G., Ghosh, P., . . . Barbieri, M. (2024). Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: Evidence for the role of tirzepatide. Cardiovascular Diabetology, 23(1), 1. https://doi.org/10.1186/s12933-024-02319-7

Chicago Style (17th ed.) Citation

Taktaz, Fatemeh, et al. "Bridging the Gap Between GLP1-receptor Agonists and Cardiovascular Outcomes: Evidence for the Role of Tirzepatide." Cardiovascular Diabetology 23, no. 1 (2024): 1. https://doi.org/10.1186/s12933-024-02319-7.

MLA (9th ed.) Citation

Taktaz, Fatemeh, et al. "Bridging the Gap Between GLP1-receptor Agonists and Cardiovascular Outcomes: Evidence for the Role of Tirzepatide." Cardiovascular Diabetology, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12933-024-02319-7.